-
2
-
-
0025177196
-
Elevation of C-reactive protein in "active" coronary artery disease
-
Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990; 65: 168-72.
-
(1990)
Am. J. Cardiol.
, vol.65
, pp. 168-172
-
-
Berk, B.C.1
Weintraub, W.S.2
Alexander, R.W.3
-
3
-
-
0037298648
-
Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris
-
Yamashita H, Shimada K, Seki E, Mokuno H, Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 2003; 91: 133-6.
-
(2003)
Am. J. Cardiol.
, vol.91
, pp. 133-136
-
-
Yamashita, H.1
Shimada, K.2
Seki, E.3
Mokuno, H.4
Daida, H.5
-
4
-
-
0031054058
-
Production of C-reactive protein and risk for coronary events in stable and unstable angina
-
for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
-
Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk for coronary events in stable and unstable angina. Lancet 1997; 349: 462-6.
-
(1997)
Lancet
, vol.349
, pp. 462-466
-
-
Haverkate, F.1
Thompson, S.G.2
Pyke, S.D.M.3
Gallimore, J.R.4
Pepys, M.B.5
-
5
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
Buring, J.E.4
Cook, N.R.5
-
6
-
-
0036581974
-
Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease
-
Auer J, Rammer M, Berent R, Weber T, Lassnig E, Eber B. Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease. Indian Heart J 2002; 54: 284-8.
-
(2002)
Indian Heart J.
, vol.54
, pp. 284-288
-
-
Auer, J.1
Rammer, M.2
Berent, R.3
Weber, T.4
Lassnig, E.5
Eber, B.6
-
7
-
-
0028969680
-
Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
-
Heinrich J, Schulte H, Schönfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemostas 1995; 73: 374-8.
-
(1995)
Thromb. Haemostas.
, vol.73
, pp. 374-378
-
-
Heinrich, J.1
Schulte, H.2
Schönfeld, R.3
Kohler, E.4
Assmann, G.5
-
8
-
-
0033799673
-
C-reactive protein: Relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men
-
Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 2000; 21: 1584-90.
-
(2000)
Eur. Heart J.
, vol.21
, pp. 1584-1590
-
-
Mendall, M.A.1
Strachan, D.P.2
Butland, B.K.3
-
9
-
-
4644243607
-
Kararli anginasi olan ve efor testi pozitif bulunan ayaktan hastalarda serum C-reaktif protein düzeyleri ile koroner arter hastaliǧi ilşkisi
-
Türkoǧlu EI, Gürgür C, Zoghi M, Türkoǧ lu C. Kararli anginasi olan ve efor testi pozitif bulunan ayaktan hastalarda serum C-reaktif protein düzeyleri ile koroner arter hastaliǧi ilşkisi. Anadolu Kardiyol Derg 2004; 4: 199-202.
-
(2004)
Anadolu. Kardiyol. Derg.
, vol.4
, pp. 199-202
-
-
Türkoǧlu, E.I.1
Gürgür, C.2
Zoghi, M.3
Türkoǧlu, C.4
-
10
-
-
0038116392
-
C-reactive protein: A novel marker of cardiovascular risk
-
Shah SH, Newby LK. C-reactive protein: A novel marker of cardiovascular risk. Cardiology in Review 2003; 11: 169-79.
-
(2003)
Cardiology in Review
, vol.11
, pp. 169-179
-
-
Shah, S.H.1
Newby, L.K.2
-
11
-
-
0037469232
-
Markers of imflammation and cardiovascular disease: Application to clinical and public health practice: A statement for health-care professionals from the Centers for Disease Control and Prevention and the American Heart Association
-
Pearson TA, Mensah GA, Alexander RW, et al. Markers of imflammation and cardiovascular disease: Application to clinical and public health practice: A statement for health-care professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
-
(2003)
Circulation
, vol.107
, pp. 499-511
-
-
Pearson, T.A.1
Mensah, G.A.2
Alexander, R.W.3
-
12
-
-
0031946651
-
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
-
Dev D, Wallace E, Sankaran R, Cunniffe J, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med 1998; 92: 664-7.
-
(1998)
Respir. Med.
, vol.92
, pp. 664-667
-
-
Dev, D.1
Wallace, E.2
Sankaran, R.3
Cunniffe, J.4
-
13
-
-
0035963529
-
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
-
Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles S. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-65.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1959-1965
-
-
Ridker, P.M.1
Rifai, N.2
Clearfield, M.3
Downs, J.R.4
Weis, S.E.5
Miles, S.6
-
14
-
-
0032169240
-
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
-
Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998; 98: 839-44.
-
(1998)
Circulation
, vol.98
, pp. 839-844
-
-
Ridker, P.M.1
Rifai, N.2
Pfeffer, M.A.3
-
15
-
-
0033578463
-
Effect of postmenopausal hormones on iflammation-sensitive proteins: Postmenopausal Estrogen/Progestin Interventions (PEPI) study
-
Cushman M, Legault C, Barret-Connor E, et al. Effect of postmenopausal hormones on iflammation-sensitive proteins: Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation 1999; 100: 717-22.
-
(1999)
Circulation
, vol.100
, pp. 717-722
-
-
Cushman, M.1
Legault, C.2
Barret-Connor, E.3
-
16
-
-
0033578485
-
Hormone replacement therapy and increased plasma concentration of C-reactive protein
-
Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999; 100: 713-6.
-
(1999)
Circulation
, vol.100
, pp. 713-716
-
-
Ridker, P.M.1
Hennekens, C.H.2
Rifai, N.3
Buring, J.E.4
Manson, J.E.5
-
17
-
-
0041334208
-
Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women
-
Ylikorkala O, Evio S, Valimaki M, Tiitinen A. Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women. Fertil Steril 2003; 80: 541-5.
-
(2003)
Fertil. Steril.
, vol.80
, pp. 541-545
-
-
Ylikorkala, O.1
Evio, S.2
Valimaki, M.3
Tiitinen, A.4
-
19
-
-
4644257052
-
Tibbi Araştirmalarda Sik Kullanilan ̇ Istatistik Yöntemler-1
-
Çapaci K. Tibbi Araştirmalarda Sik Kullanilan ̇Istatistik Yöntemler-1. Ege Fiz Tip Reh Derg 2000; 6: 27-35.
-
(2000)
Ege. Fiz. Tip. Reh. Derg.
, vol.6
, pp. 27-35
-
-
Çapaci, K.1
|